Rose merc Limited has announced the resignation of its Managing Director, Mr. Kirti Savla, effective January 21, 2026. The company informed BSE Limited about this key leadership change in compliance with regulatory requirements, marking a significant transition in the company's management structure.

Resignation Details and Regulatory Compliance

The resignation was formally communicated to BSE Limited under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Executive Director Vaishali Parkar Kumar signed the official intimation on behalf of Rose Merc Limited, ensuring full regulatory compliance.

Health Reasons Drive Leadership Change

Mr. Savla cited personal health reasons as the primary factor behind his decision to resign from the Managing Director position. In his resignation letter, he emphasized that these health concerns require his full attention, necessitating his departure from the leadership role. The company has confirmed that there are no other material reasons for his resignation, providing transparency to stakeholders.

Positive Transition Message

Despite stepping down, Mr. Savla expressed strong confidence in the company's management and future prospects. In his resignation letter, he stated his happiness with the way management has been functioning and praised the professionalism, dedication, and teamwork witnessed during his tenure. He assured the Board of his full support for a smooth transition process and offered assistance during the handover period.

Regulatory Documentation

The company has submitted comprehensive documentation to BSE Limited, including the formal resignation letter and annexures as required under SEBI regulations. The submission includes details mandated by SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, ensuring complete regulatory compliance during this leadership transition.

The resignation represents a significant change in Rose Merc Limited's leadership structure, with the company now focusing on ensuring continuity in operations and management effectiveness during this transition period.

Rose Merc Limited announced comprehensive board meeting outcomes on January 20, 2026, covering multiple strategic business approvals including loan facilities, investments, and equity warrant issuance. The board meeting, conducted from 3:00 PM to 4:45 PM, addressed significant corporate developments across various business segments.

Loan Facility and Financial Arrangements

The board ratified substantial loan arrangements involving the company's promoter and subsidiary operations. Key financial approvals included ratification of existing loans and authorization for additional funding.

Equity Warrant Issuance to Non-Promoters

The company approved a significant equity warrant issuance targeting non-promoter investors. The preferential allotment involves 2,41,500 equity warrants convertible into equity shares.

The warrant allocation covers ten non-promoter investors, with major subscriptions including Kavita Deshpande (50,000 warrants), Sachin Deshpande (50,000 warrants), Salil Divakar Deshpande (50,000 warrants), Vedika Thakur (40,000 warrants), and Vikas Kamlakar Phadnis (50,000 warrants).

Investment and Divestment Activities

The board approved multiple investment transactions involving subsidiary and associate companies. Notable decisions included equity share subscriptions and strategic divestments.

Abaca Care Private Limited operates in the organic healthcare sector, specifically developing homeopathy pain relief products. The company was incorporated on May 17, 2023, and reported turnover of ₹20,755.78 for 2024-25 after nil revenue in 2023-24.

Corporate Restructuring and Closures

The board identified three companies for operational closure or complete exit:

• Kaale and Rose Merc Advisors Private Limited (Subsidiary Company)
• Hyderabad Sports Leagues Private Limited (Step down Subsidiary)
• Parshuram Creative Craft Private Limited (Associate Company)

Leadership Appointment

Ms. Eshwari Purvesh Shelatkar (DIN: 10973309) was appointed as Additional Executive Director effective January 20, 2026, with a five-year term until January 20, 2031, subject to shareholder approval. She is the daughter of existing Executive Director Mr. Purvesh Krishna Shelatkar (DIN: 09838204).

Ms. Shelatkar brings diverse experience across fashion, spiritual tourism, trading, and sports sectors. She received the Emirates Luxury Show Award in Dubai for Eshwariy Shakti Spiritual Tourism and manages social media marketing for the parent company and twelve associate businesses. Her portfolio includes oversight of high-visibility projects such as the Navi Mumbai Premier League marketing distribution across radio, television, and OTT platforms.

Regulatory Compliance

All approved transactions comply with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and related circulars. The equity warrant issuance follows SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, with proper regulatory disclosures provided for each transaction category.